In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...
A personalized mRNA vaccine for pancreatic cancer has shown early promise in a small phase 1 trial of 16 people. A mRNA-based cancer vaccine has shown impressive results in a small trial in patients ...
Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their potential to revolutionize medicine. At Memorial Sloan Kettering Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback